Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)

PHASE3CompletedINTERVENTIONAL
Enrollment

2,054

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Asthma
Interventions
DRUG

Roflumilast

Trial Locations (24)

Unknown

ALTANA Pharma, Cities in Georgia

ALTANA Pharma, Cities in Austria

ALTANA Pharma, Cities in Croatia

ALTANA Pharma, Cities in the Czech Repulik

ALTANA Pharma, Cities in Finland

ALTANA Pharma, Cities in France

ALTANA Pharma, Cities in Greece

ALTANA Pharma, Cities in Hungary

ALTANA Pharma, Cities in India

ALTANA Pharma, Cities in Ireland

ALTANA Pharma, Cities in Italy

ALTANA Pharma, Cities in New Zealand

ALTANA Pharma, Cities in Norway

ALTANA Pharma, Cities in Pakistan

ALTANA Pharma, Cities in the Philippines

ALTANA Pharma, Cities in Poland

ALTANA Pharma, Cities in Portugal

ALTANA Pharma, Cities in the Russian Federation

ALTANA Pharma, Sites in Singapore

ALTANA Pharma, Cities in South Africa

ALTANA Pharma, Cities in Spain

ALTANA Pharma, Cities in Taiwan

ALTANA Pharma, Cities in Thailand

ALTANA Pharma, Cities in the United Kindom

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

AstraZeneca

INDUSTRY